Elif Eyigoz PhD: Linguistic Markers for Alzheimer's Risk

Linguistic patterns serve as effective, non-invasive biomarkers for predicting the future onset of Alzheimer’s disease in cognitively normal individuals. Researcher Elif Eyigoz, from IBM Watson Labs, utilizes data from the Framingham Heart Study to demonstrate that computational analysis of speech—specifically picture description tasks—identifies early cognitive decline years before clinical diagnosis. Key findings indicate that a decrease in referential specificity, such as using generic terms instead of specific relationship descriptors, correlates with higher disease risk. By integrating these linguistic variables with traditional clinical data, predictive models achieve significantly higher accuracy than using medical history or genetic markers alone. These naturalistic speech probes offer a scalable, low-burden tool for early intervention, potentially allowing for remote monitoring and timely medical consultation before significant cognitive impairment manifests.